Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service

Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. Methods A cross-sectional analysis of 91 393 persons with diabetes, 5003 type 1 diabetes and 86 390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye. Results The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes. Conclusions Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population.

[1]  E. Stefánsson,et al.  The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus , 2014, Acta ophthalmologica.

[2]  J. Olson,et al.  Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland , 2012, Diabetologia.

[3]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[4]  S. Sonoda,et al.  Intravitreous VEGF-A in eyes with massive vitreous hemorrhage , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[5]  H. Hammes,et al.  Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients , 2011, Diabetologia.

[6]  M. Fowler,et al.  Clinical Practice Recommendations , 2009, Clinical Diabetes.

[7]  Ann L. Albright,et al.  Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.

[8]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[9]  M. Bachmann,et al.  Trends in yield and effects of screening intervals during 17 years of a large UK community‐based diabetic retinopathy screening programme , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[10]  G Chaine,et al.  Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. , 2009, Diabetes & metabolism.

[11]  C. Creuzot-Garcher,et al.  Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. , 2009, Diabetes & metabolism.

[12]  M. Fowler Clinical Practice Recommendations , 2009, Clinical Diabetes.

[13]  C. Bunce,et al.  Causes of blind certifications in England and Wales: April 1999–March 2000 , 2008, Eye.

[14]  P. Scanlon,et al.  Article Commentary: The English national screening programme for sight-threatening diabetic retinopathy , 2008, Journal of medical screening.

[15]  Z. Bloomgarden,et al.  Screening for and managing diabetic retinopathy: current approaches. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[16]  E. Stefánsson,et al.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience , 2007, British Journal of Ophthalmology.

[17]  Richard Wormald,et al.  Leading causes of certification for blindness and partial sight in England & Wales , 2006, BMC public health.

[18]  K. Angioi,et al.  Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. , 2005, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[19]  J. Silverstein,et al.  Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus , 2005, Pediatrics.

[20]  R Greenwood,et al.  Grading and disease management in national screening for diabetic retinopathy in England and Wales , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Graham P. Leese,et al.  A national retinal screening programme for diabetes in Scotland , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[22]  N. Younis,et al.  Prevalence of diabetic eye disease in patients entering a systematic primary care‐based eye screening programme , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[23]  Nathan Congdon,et al.  The Prevalence of Diabetic Retinopathy in the United States , 2002 .

[24]  S. Harding,et al.  Current status of screening for diabetic retinopathy in the UK , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J Clowes,et al.  Preservation of sight in diabetes: developing a national risk reduction programme , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[26]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[27]  P. Fowler The UK Prospective Diabetes study , 1998, The Lancet.

[28]  N. Chaturvedi,et al.  The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner‐city district of North London: a quality of care study , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[29]  Stephen J. Aldington,et al.  United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. , 1998, Archives of ophthalmology.

[30]  R. Holman,et al.  U.K. Prospective Diabetes Study , 1996, Diabetes Care.

[31]  E. Stefánsson,et al.  Screening for eye disease in type 2 diabetes mellitus , 1994, Acta ophthalmologica.

[32]  E. Stefánsson,et al.  Systematic screening for diabetic eye disease in insulin dependent diabetes , 1994, Acta ophthalmologica.

[33]  D. Spiegelhalter,et al.  Screening for Treatable Diabetic Retinopathy: a Comparison of Different Methods , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[34]  A Protocol for Screening for Diabetic Retinopathy in Europe , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[35]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[36]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[37]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.